Understanding the Transformation: Unpacking International Tobacco Legislation, Upcoming TPD Changes, FDA CTP’s Role, and the Evolving Global Regulatory Scenario Read More
1 min. read
1 min. read
Understanding the Transformation: Unpacking International Tobacco Legislation, Upcoming TPD Changes, FDA CTP’s Role, and the Evolving Global Regulatory Scenario Read More
13 min. read
Hi, I’m Ian Fearon I’m the Director of WhatIF? Consulting Limited and Chief Scientific Officer with McKinney Regulatory Science Advisors. […] Read More
6 min. read
Hello, I am Mark Crosswhite, and I’m happy to be presenting data that were predominantly sourced from the youth risk […] Read More
12 min. read
Dr. Willie McKinney presents on the the importance of a toxicological risk assessment on your products before releasing them for […] Read More
3 min. read
On August 22, 2023 our very own Dr. Willie McKinney, CEO, had the opportunity to express his views and opinions […] Read More
14 min. read
For their patients who can’t or won’t stop smoking with medication options… Introducing doctors to the most common reduced-harm alternative […] Read More
4 min. read
It’s no secret that the FDA’s requirements for investigational tobacco product (ITP) applications can be confusing. But what if you […] Read More
6 min. read
By Cheryl K. Olson As part of its new strategic plan, the U.S. Food and Drug Administration’s Center for Tobacco Products […] Read More
6 min. read
by Cheryl K. Olson, M.P.H., Sc.D, originally featured in the Tobacco Reporter On August 22, the U.S. Food and Drug Administration’s […] Read More
"*" indicates required fields